Brent Warner

Brent Warner is a co-founder of Protego Biopharma, a company operating in the biotechnology research sector. Protego Biopharma at the forefront of drug discovery targeting protein misfolding diseases. Based in San Diego, California, United States, Brent leads the company's strategic vision and day-to-day operations.

Under Brent's leadership, Protego Biopharma recently secured $130M in Series B funding on Dec 1, 2025, backed by investors including Novartis Venture Fund. This funding milestone reflects strong investor confidence in both the founding team's execution capabilities and the company's market opportunity.

With fresh capital, Brent and the team are focused on scaling operations, expanding the product roadmap, and building out a world-class team. The biotechnology research market continues to see significant investment activity, positioning Protego Biopharma to capitalize on growing demand.For vendors and partners, this represents an ideal window to engage.